Multiple Myeloma in the Era of Novel Agents: A Single-Center Study

被引：0
|
作者：
Lopes, Danielle Ovigli [1 ]
Arcuri, Leonardo [1 ]
Marques, Carolina [1 ]
Kerbauy, Mariana [1 ]
Moura, Fernando [1 ]
Helman, Ricardo [1 ]
Silva, Cinthya [1 ]
RIbeiro, Andreza [1 ]
Hamerschlak, Nelson [1 ]
机构：
[1] Hosp Israelita Albert Einstein, Sao Paulo, Brazil
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-261
引用
收藏
页码：S187 / S188
页数：2
相关论文
共 50 条
  • [41] Anti-BCMA therapy in multiple myeloma: a single-center experience
    Puertas, Borja
    Fernandez, Adolfo
    Jara, Mirian
    Hernandez, Alberto
    Gomez, Sandra
    Alejo, Elena
    Alonso, David
    Maria Navarro, Jose
    Rey, Bea
    Fonseca, Marta
    Avendano, Alejandro
    Baile, Monica
    Cabero, Almudena
    Cabrero, Monica
    Lopez, Miriam
    Perez, Estefania
    Martin, Ana
    Lopez, Lucia
    Puig, Noemi
    Gonzalez, Veronica
    Mateos, Maria-Victoria
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S96 - S97
  • [42] Carfilzomib experience in relapsed/refractory multiple myeloma: a single-center experience
    Uysal, Ayse
    Akad Soyer, Nur
    Ozkan, Melda
    Sahin, Fahri
    Vural, Filiz
    Tobu, Mahmut
    Tombuloglu, Murat
    Saydam, Guray
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2018, 48 (01) : 80 - 83
  • [43] Long-term survival in multiple myeloma: a single-center experience
    Francesca Merchionne
    Pasquale Procaccio
    Franco Dammacco
    Clinical and Experimental Medicine, 2008, 8 : 133 - 139
  • [44] Long-term survival in multiple myeloma: a single-center experience
    Merchionne, Francesca
    Procaccio, Pasquale
    Dammacco, Franco
    CLINICAL AND EXPERIMENTAL MEDICINE, 2008, 8 (03) : 133 - 139
  • [45] Anti-BCMA Therapy in Multiple Myeloma: A Single-Center Experience
    Puertas, Borja
    Fernandez, Adolfo
    Jara, Mirian
    Hernandez, Alberto
    Gomez, Sandra
    Alejo, Elena
    Maria Navarro, Jose
    Alonso, David
    Fonseca, Marta
    Rey, Beatriz
    Avendano, Alejandro
    Baile, Monica
    Cabero, Almudena
    Cabrero, Monica
    Lopez, Miriam
    Perez, Estefania
    Martin, Ana
    Lopez, Lucia
    Puig, Noemi
    Gonzalez-Calle, Veronica
    Victoria Mateos, Maria
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S413 - S413
  • [46] Clinical Characteristics and Prognosis of Multiple Myeloma With Myelomatous Pleural Effusion: A Retrospective Single-Center Study
    Gao, Liang
    Xu, Junhui
    Xie, Weiwei
    Wang, Bingjie
    Cen, Xinan
    Wang, Mangju
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2022, 21
  • [47] Real-world experience of novel multiple myeloma treatments in a large, single-center cohort in Finland
    Loponen, Heidi
    Mehtala, Juha
    Ylisaukko-oja, Tero
    Bruck, Oscar
    Porkka, Kimmo
    Koskenvesa, Perttu
    Saukkonen, Kirsi
    Lievonen, Juha
    EJHAEM, 2023, 4 (04): : 1019 - 1029
  • [48] Salvage second autologous stem cell transplant for relapsed multiple myeloma in the novel agent era benefits a subset of patients: single-center UK experience
    Richards, Huw
    Chavda, Selina J.
    Wilson, William
    Camilleri, Marquita
    Cohen, Oliver
    Horder, Jackie
    Newrick, Fiona
    Papanikolaou, Xenofon
    Sive, Jonathan
    Lee, Lydia
    Popat, Rakesh
    Wechalekar, Ashutosh
    Kyriakou, Charalampia
    Yong, Kwee
    Rabin, Neil
    LEUKEMIA & LYMPHOMA, 2021, 62 (14) : 3544 - 3547
  • [49] Novel investigational drugs active as single agents in multiple myeloma
    D'Agostino, Mattia
    Salvini, Marco
    Palumbo, Antonio
    Larocca, Alessandra
    Gay, Francesca
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017, 26 (06) : 699 - 711
  • [50] Novel Agents in Multiple Myeloma
    Szalat, Raphael
    Munshi, Nikhil C.
    CANCER JOURNAL, 2019, 25 (01): : 45 - 53
12345